Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
Clinical trial NCT02657447 · WITHDRAWN
Trial details
- NCT number
- NCT02657447
- Sponsor
- Nordic Nanovector
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2019-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.